Guiding the „misguided“ – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
/in Dendritic Cells, International PublicationsGene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
/in Dendritic Cells, Glioblastoma, International PublicationsImmunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
/in Colorectal Cancer, Dendritic Cells, International PublicationsTranscriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusNew approaches to the development of adenoviral dendritic cell vaccines in melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaEffect of hyperthermia on the apoptosis and proliferation of CaSki cells
/in Cervical Cancer, Hyperthermia, International PublicationsHyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
/in Hyperthermia, International PublicationsHyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
/in Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer